Compare NYT & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NYT | TECH |
|---|---|---|
| Founded | 1851 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2B | 11.2B |
| IPO Year | 1994 | 1995 |
| Metric | NYT | TECH |
|---|---|---|
| Price | $75.76 | $72.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $72.14 | $71.82 |
| AVG Volume (30 Days) | 1.4M | ★ 3.9M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.16% | 0.62% |
| EPS Growth | ★ 18.08 | N/A |
| EPS | 0.54 | ★ 0.81 |
| Revenue | ★ $1,783,639,000.00 | $1,219,635,000.00 |
| Revenue This Year | $10.58 | $2.49 |
| Revenue Next Year | $6.98 | $6.40 |
| P/E Ratio | $138.69 | ★ $89.00 |
| Revenue Growth | N/A | ★ 5.23 |
| 52 Week Low | $53.48 | $43.20 |
| 52 Week High | $87.10 | $72.37 |
| Indicator | NYT | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 53.07 | 74.99 |
| Support Level | $72.59 | $70.49 |
| Resistance Level | $76.76 | N/A |
| Average True Range (ATR) | 2.20 | 0.33 |
| MACD | 0.23 | -0.61 |
| Stochastic Oscillator | 65.49 | 80.09 |
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company derives revenue from subscriptions, advertising, and other sources, where the majority of its revenue is generated through subscriptions, which consist of income from standalone and multiproduct bundle subscriptions to its digital products and subscriptions to and single-copy and bulk sales of print products.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.